Interesting MRK Put And Call Options For October 18th
moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]
MRK
A Big Pharma Titan Prepares For the Next Generation
moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]
People Moves: Morrison & Foerster, SAC Capital, SEC
moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]
Interesting MRK Put And Call Options For June 21st
moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]
Merck Serono CEO Eyes Asia for Growth in Cancer, Fertility Drugs
moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]
A Fracturing Industry Is Forcing Merck to Make Touch Choices
moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]
Merck to Participate in the Citi 2014 Healthcare Conference
[Business Wire] – Merck , known as MSD outside the United States and Canada, announced today that Dr. Roger M. Perlmutter, president, Merck Research Laboratories, is scheduled to speak at the Citi 2014 Healthcare Conference in New York City on February 2 moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who […]
FDA to Review Merck’s New HPV Vaccine
moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]
8:32 am Merck announces the Biologics License Application for V503, its investigational 9-valent human papillomavirus vaccine, has been accepted for standard review by the FDA
moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]
FDA Accepts for Review Merck’s Biologics License Application for V503, Investigational 9-valent Human Papillomavirus Vaccine
[Business Wire] – Merck , known as MSD outside the United States and Canada, announced today that the Biologics License Application for V503, its investigational 9-valent human papillomavirus vaccine, has been accepted for standard review by the U.S. moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, […]
